Press release
Digital Therapeutics (DTx) Market is expected to grow US$ 26.84 billion by 2029, at a CAGR of 25.4%.
Digital Therapeutics (DTx) Market
"The global digital therapeutics (DTx) market is expected to grow at 25.4% CAGR from 2022 to 2029. It is expected to reach above USD 26.84 billion by 2029 from USD 3.5 billion in 2020."
Download FREE Sample Report @ https://exactitudeconsultancy.com/reports/7904/digital-therapeutics-dtx-market/#request-a-sample
Our professionals analyze data using industry methodologies, focusing on downstream needs and upstream crude materials. They examine key market participants and provide a detailed breakdown of growth potential areas. The Digital Therapeutics (DTx) study report measures market growth in terms of size, share, demand, usage patterns, and revenue, highlighting significant market participants and observed trends.
The report provides a comprehensive analysis of company profiles listed below:
-Noom
-Livongo Health
-Omada Health
-WellDoc
-Pear Therapeutics
-Proteus Digital Health
-Propeller Health
-Akili Interactive Labs
-Better Therapeutics
-Happify
-Kaia Health
-Mango Health
-Click Therapeutics.
Recent Developments
In February 2022, Biofourmis announced the launch of Biofourmis Care, a technology-enabled care management service that delivers high-quality remote care for patients with chronic conditions. The service includes automated medication management to augment and assist care teams in remotely adjusting medications for optimal personalized therapy. This strategic launch helped the company to improve health outcomes in the market and reduce total cost of care among patients, thereby gaining significant industry revenue.
Digital Therapeutics (DTx) Market Segment by Product Type:
- Software
-Devices
Digital Therapeutics (DTx) Market Segment By Sales Channel:
- Business-To-Business (B2b)
- Business-To-Consumers(B2c)
Digital Therapeutics (DTX) Market By Application
- Diabetes
- Obesity
- Cardio Vascular Diseases (CVD)
- Central Nervous System (CNS) Disease
- Respiratory Diseases
- Smoking Cessation
- Gastrointestinal Disorders
- Others
The report provides a comprehensive analysis of the global Digital Therapeutics (DTx) market, focusing on regional and country-level size, CAGR estimation, revenue, major drivers, competition, and payers' sales. It also discusses risks and difficulties, and divides the market into Type and Application segments. The research serves as a valuable resource for market participants, enabling them to gain an advantage.
Scope of this Report:
• This study thoroughly segmented the global Digital Therapeutics (DTx) market, providing accurate revenue estimates across various industries and geographical areas.
• The study gives stakeholders information on the major market drivers, restraints, challenges, and opportunities, as well as the pulse of the Digital Therapeutics (DTx) market.
• This study aims to enhance stakeholders' understanding of competitors, strengthen their positions in industries, and cover aspects such as rival ecosystem, new product development, agreements, and acquisitions in the competitive landscape.
Get a Sample Copy of the Digital Therapeutics (DTx) Market Research Report (Use Corporate mail id for quick response)-@ https://exactitudeconsultancy.com/reports/7904/digital-therapeutics-dtx-market/#request-a-sample
#Customization Service of the Report:
Exactitude Consultancy provides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.
Healthcare Trending Reports
https://www.openpr.com/news/3216907/hospital-mobile-xray-market-size-is-projected-to-reach-17-2
https://www.openpr.com/news/3216959/bioglass-market-is-expected-to-progress-to-reach-us-18-64
About Us
Exactitude Consultancy is a Market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our professional team works hard to fetch the most authentic research reports backed with impeccable data figures which guarantee outstanding results every time for you. So, whether it is the latest report from the researchers or a custom requirement, our team is here to help you in the best possible way.
Connect Us:
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Digital Therapeutics (DTx) Market is expected to grow US$ 26.84 billion by 2029, at a CAGR of 25.4%. here
News-ID: 3218070 • Views: …
More Releases from Exactitude Consultancy
Huntington's Disease Market to Set Phenomenal Growth From 2025 to 2034
Introduction
Huntington's Disease (HD) is a devastating rare, inherited neurodegenerative disorder that progressively impairs movement, cognition, and behavior. Affecting approximately 3 to 7 individuals per 100,000 globally, it continues to challenge patients, caregivers, and healthcare systems. Despite being rare, the growing investment in research, clinical trials, and novel treatment approaches is transforming the Huntington's Disease market into a promising frontier for biopharmaceutical innovation.
The global Huntington's Disease market is poised for strong…
Hemophilia B Market Emerging Trends and Growth Prospects 2034
Introduction
Hemophilia B is a rare, inherited bleeding disorder caused by a deficiency or dysfunction of clotting factor IX (FIX). Patients with Hemophilia B experience prolonged bleeding episodes, spontaneous internal hemorrhages, and joint damage, which can significantly impair quality of life. The disease predominantly affects males, with an estimated 1 in 25,000 male births worldwide.
For decades, the mainstay of treatment has been factor IX replacement therapy, delivered intravenously. However, repeated infusions,…
Lupus Nephritis Patient Pool Analysis Market is expected to reach USD 15.2 billi …
Lupus nephritis (LN) is a severe manifestation of systemic lupus erythematosus (SLE), an autoimmune disease where the immune system attacks the body's own tissues. LN affects the kidneys, causing inflammation that can lead to organ damage and, if left untreated, kidney failure. With SLE most commonly affecting women of childbearing age, lupus nephritis represents a significant clinical and socioeconomic burden worldwide.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71619
The…
Facioscapulohumeral Muscular Dystrophy (FSHD) Market Massive Growth opportunity …
Introduction
Facioscapulohumeral muscular dystrophy (FSHD) is a rare genetic muscle disorder characterized by progressive weakness of facial, shoulder, and upper arm muscles, and eventually lower body muscles. It is the third most common type of muscular dystrophy, affecting approximately 1 in 8,000 to 1 in 20,000 individuals worldwide.
FSHD is typically caused by abnormal expression of the DUX4 gene due to genetic mutations on chromosome 4. While there is currently no approved…
More Releases for Therapeutics
Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years.
DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Some of the…
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years.
DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,…
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611
Focused on growth…
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan.
Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Hodgkin's…
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space.
Key Takeaways from…
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…
